Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News C2N Diagnostics bags UK MHRA approval for PrecivityAD2 blood test, advancing Alzheimer’s diagnosis C2N Diagnostics, LLC, a leader in advanced diagnostic solutions for neurodegenerative diseases, has obtained medical device certification from… byPallavi MadhirajuFebruary 25, 2025